Update on dietary intake of perchlorate and iodine from U.S. food and drug administration’s total diet study: 2008–2012

被引:0
|
作者
Eileen Abt
Judith Spungen
Régis Pouillot
Margaret Gamalo-Siebers
Mark Wirtz
机构
[1] US Food and Drug Administration,
[2] Center for Food Safety and Applied Nutrition,undefined
[3] 2Present address: Eli Lilly & Co,undefined
[4] Lilly Corporate Center,undefined
[5] Indianapolis,undefined
[6] IN 46285,undefined
[7] USA.,undefined
关键词
dietary intake; exposure; iodine; left-censored data; perchlorate; total diet study;
D O I
暂无
中图分类号
学科分类号
摘要
The U.S. Food and Drug Administration’s (FDA) Total Diet Study (TDS) monitors the US food supply for pesticide residues, industrial chemicals, radionuclides, nutrients, and toxic elements. Perchlorate and iodine intakes based on concentrations in TDS samples collected between 2008 and 2012 were estimated in order to update an earlier TDS dietary assessment. Perchlorate is used as an oxidizing agent in rocket and missile fuel, is formed naturally in the atmosphere, and occurs naturally in some soils. Because of perchlorate’s presence in soil, and in irrigation, processing, and source water, it is widely found in food. Iodine was included in the study because perchlorate at high doses interferes with iodide uptake in the thyroid. Iodine (the elemental form of iodide) is essential for growth and development, and metabolism. This study uses a novel statistical method based on a clustered zero-inflated lognormal distribution model to estimate mean and 95th percentile confidence interval concentrations for perchlorate and iodine in US foods. These estimates were used to estimate mean perchlorate and iodine exposures for the total US population and for 14 age/sex groups in the US population. Estimated mean perchlorate intake for the total US population was 0.13 μg/kg bw/day, with mean intakes for the 14 age/sex groups between 0.09 and 0.43 μg/kg bw/day. The estimated mean intakes of perchlorate for all age/sex groups were below EPA’s reference dose (RfD) of 0.7 μg/kg bw/day. The estimated mean iodine intake for the total US population was 216.4 μg/person/day, with mean intakes ranging from 140.9 to 296.3 μg/person/day for the 14 age/sex groups, with all age/sex groups exceeding their respective estimated average requirements (EARs).
引用
收藏
页码:21 / 30
页数:9
相关论文
共 50 条
  • [41] U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma
    Axelson, Michael
    Liu, Ke
    Jiang, Xiaoping
    He, Kun
    Wang, Jian
    Zhao, Hong
    Kufrin, Dubravka
    Palmby, Todd
    Dong, Zedong
    Russell, Anne Marie
    Miksinski, Sarah
    Keegan, Patricia
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2013, 19 (09) : 2289 - 2293
  • [42] ACMT Position Statement: Position on the Recent Judicial Challenge of U.S. Food and Drug Administration Approval of Mifepristone
    Maryann Mazer-Amirshahi
    Andrew I. Stolbach
    Peggy Ye
    Journal of Medical Toxicology, 2023, 19 : 414 - 415
  • [43] Hysteroscopic Sterilization With Essure Summary of the U.S. Food and Drug Administration Actions and Policy Implications for Postmarketing Surveillance
    Walter, Jessica R.
    Ghobadi, Comeron W.
    Hayman, Emily
    Xu, Shuai
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (01): : 10 - 19
  • [44] U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients with Intermediate and High-Risk Myelofibrosis
    Deisseroth, Albert
    Kaminskas, Edvardas
    Grillo, Joseph
    Chen, Wei
    Saber, Haleh
    Lu, Hong L.
    Rothmann, Mark D.
    Brar, Satjit
    Wang, Jian
    Garnett, Christine
    Bullock, Julie
    Burke, Laurie B.
    Rahman, Atiqur
    Sridhara, Rajeshwari
    Farrell, Ann
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3212 - 3217
  • [45] Correction to: Descriptive Analysis of Good Clinical Practice Inspection Findings from U.S. Food and Drug Administration and European Medicines Agency
    Jenn W. Sellers
    Camelia M. Mihaescu
    Kassa Ayalew
    Phillip D. Kronstein
    Bei Yu
    Yang-Min Ning
    Miguel Rodriguez
    LaKisha Williams
    Ni A. Khin
    Therapeutic Innovation & Regulatory Science, 2022, 56 : 767 - 767
  • [46] Kuwait's total diet study: Dietary intake of organochlorine, carbamate, benzimidazole and phenylurea pesticide residues
    Sawaya, Wajih N.
    Al-Awadhi, Fawzia A.
    Saeed, Talat
    Al-Omair, Ali
    Ahmad, Nissar
    Husain, Adnan
    Khalafawi, Sherif
    Al-Omirah, Husam
    Dashti, Basma
    Al-Amiri, Hanan
    Al-Saqer, Jameela
    Journal of AOAC International, 82 (06): : 1458 - 1465
  • [47] Kuwait's Total Diet Study: Dietary intake of organochlorine, carbamate, benzimidazole and phenylurea pesticide residues
    Sawaya, WN
    Al-Awadhi, FA
    Saeed, T
    Al-Omair, A
    Ahmad, N
    Husain, A
    Khalafawi, S
    Al-Omirah, H
    Dashti, B
    Al-Amiri, H
    Al-Saqer, J
    JOURNAL OF AOAC INTERNATIONAL, 1999, 82 (06) : 1458 - 1465
  • [48] U.S. Food and Drug Administration Approval: Obinutuzumab in Combination with Chlorambucil for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia
    Lee, Hyon-Zu
    Miller, Barry W.
    Kwitkowski, Virginia E.
    Ricci, Stacey
    DelValle, Pedro
    Saber, Haleh
    Grillo, Joseph
    Bullock, Julie
    Florian, Jeffry
    Mehrotra, Nitin
    Ko, Chia-Wen
    Nie, Lei
    Shapiro, Marjorie
    Tolnay, Mate
    Kane, Robert C.
    Kaminskas, Edvardas
    Justice, Robert
    Farrell, Ann T.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2014, 20 (15) : 3902 - 3907
  • [49] Participation of the elderly, women, and minorities in pivotal trials supporting 2011–2013 U.S. Food and Drug Administration approvals
    Nicholas S. Downing
    Nilay D. Shah
    Joseph H. Neiman
    Jenerius A. Aminawung
    Harlan M. Krumholz
    Joseph S. Ross
    Trials, 17
  • [50] Magnetic Sphincter Augmentation with the LINX Device for Gastroesophageal Reflux Disease after U.S. Food and Drug Administration Approval
    Reynolds, Jessica L.
    Zehetner, Joerg
    Bildzukewicz, Nikolai
    Katkhouda, Namir
    Dandekar, Giovanni
    Lipham, John C.
    AMERICAN SURGEON, 2014, 80 (10) : 1034 - 1038